Wiley Bros.-aintree Capital »

iShares Dow Jones US Pharm Indx shares owned by Wiley Bros.-aintree Capital

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Wiley Bros.-aintree Capital from 13F filings

Historical chart of Wiley Bros.-aintree Capital investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Wiley Bros.-aintree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Wiley Bros.-aintree Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $279k 4.0k 70.61
2024-06-30 $267k 4.0k 66.32

More positions owned by Wiley Bros.-aintree Capital

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p Scp Etf (IJR)
UnitedHealth (UNH)
Lowe's Companies (LOW)

View all positions for Wiley Bros.-aintree Capital

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Rockport Wealth
Bank of America Corporation
Brown Advisory Holdings Incorporated
LPL Financial
Royal Bank of Canada
Goldman Sachs Group
Wells Fargo & Company
Pallas Capital Advisors
Susquehanna International
Raymond James & Associates
Peapack Gladstone Financial Corp
Commonwealth Equity Services
UBS Group
Thrivent Financial for Lutherans

View all funds holding iShares Dow Jones US Pharm Indx